In an article on Forbes, Mark Rogowsky gave an overview of Tesla Motors Inc (NASDAQ:TSLA)’s overall market strategy and future plans. Rogowsky referred to the current stir that has been caused by some news of depletion in Tesla Motors Inc (NASDAQ:TSLA)’s demand in the US. The company is set to roll out its quarterly report. Tesla has a yearly target of delivering around 35,000 cars for the year. He thinks that the minute issues are not of that importance as long as the company maintains its quarterly target of 7,800 vehicles. He also talked about Model X and said that year 2015 will probably be the launch date of Model X. There are already 20,000 reservations for the upcoming model.
Tesla Motors Inc (NASDAQ:TSLA) is persistent in its claims that the constraints, if any, are on the supply side. The company wants to touch the production figure of 1,000 vehicles per week this quarter. It has also vowed to double its production within a year. The source thinks that so far, the production ramp is slow but steady and there are no major glitches to raise the eyebrows of investors.
Tesla Motors Inc (NASDAQ:TSLA)’s major problem is its tussle with rowdy and unruly dealership monopoly. Tesla Motors Inc (NASDAQ:TSLA) suffered a major blow recently when Michigan State passed a law forcing the company to sell its cars through dealerships instead of its own stores. The article mentions several roadmaps for Tesla Motors Inc (NASDAQ:TSLA) in order to tackle this problem. The first is going to courts and fighting the legal battle, but this, as the source claims, is very slow and exhausting. The second is to amend state laws of dealership and it is close to impossible. The third and most suitable option for Elon Musk is to sign deals with franchisees for selling cars. Musk recently admitted in an interview that a hybrid model for selling Tesla Motors Inc (NASDAQ:TSLA) cars is probably the only reasonable option left.
Tesla Motors Inc (NASDAQ:TSLA) shareholders includes Daniel Benton’s Andor Capital Management which reported owning 1.25 million shares in the company by the end of the second quarter.
Suggested Articles:
Best Paying Medical Jobs Without Degree
